Literature DB >> 17872931

New methods of analysing cost effectiveness.

Andrew H Briggs.   

Abstract

Mesh：

Year:  2007        PMID： 17872931      PMCID： PMC1995490          DOI： 10.1136/bmj.39332.587581.BE

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Markov chain Monte Carlo estimation of a multiparameter decision model: consistency of evidence and the accurate assessment of uncertainty.

Authors:  A E Ades; S Cliffe
Journal:  Med Decis Making       Date:  2002 Jul-Aug       Impact factor: 2.583

2.  A rational framework for decision making by the National Institute For Clinical Excellence (NICE).

Authors:  Karl Claxton; Mark Sculpher; Michael Drummond
Journal:  Lancet       Date:  2002-08-31       Impact factor: 79.321

3.  Use and misuse of the term "cost effective" in medicine.

Authors:  P Doubilet; M C Weinstein; B J McNeil
Journal:  N Engl J Med       Date:  1986-01-23       Impact factor: 91.245

Review 4.  Prenatal screening and treatment strategies to prevent group B streptococcal and other bacterial infections in early infancy: cost-effectiveness and expected value of information analyses.

Authors:  T Colbourn; C Asseburg; L Bojke; Z Philips; K Claxton; A E Ades; R E Gilbert
Journal:  Health Technol Assess       Date:  2007-08       Impact factor: 4.014

Review 5.  Preventive strategies for group B streptococcal and other bacterial infections in early infancy: cost effectiveness and value of information analyses.

Authors:  Tim E Colbourn; Christian Asseburg; Laura Bojke; Zoe Philips; Nicky J Welton; Karl Claxton; A E Ades; Ruth E Gilbert
Journal:  BMJ       Date:  2007-09-11
  5 in total
  4 in total

1.  Rapid implementation of new TB diagnostic tests: is it too soon for a global roll-out of Xpert MTB/RIF?

Authors:  Daniela E Kirwan; María Kathia Cárdenas; Robert H Gilman
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

2.  Cost effectiveness of leukotriene receptor antagonists versus long-acting beta-2 agonists as add-on therapy to inhaled corticosteroids for asthma: a pragmatic trial.

Authors:  Edward C F Wilson; David Price; Stanley D Musgrave; Erika J Sims; Lee Shepstone; Jamie Murdoch; H Miranda Mugford; Annie Blyth; Elizabeth F Juniper; Jon G Ayres; Stephanie Wolfe; Daryl Freeman; Richard F T Gilbert; Elizabeth V Hillyer; Ian Harvey
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

3.  A method for addressing research gaps in HTA, developed whilst evaluating robotic-assisted surgery: a proposal.

Authors:  Luciana Ballini; Silvia Minozzi; Antonella Negro; Giampiero Pirini; Roberto Grilli
Journal:  Health Res Policy Syst       Date:  2010-09-20

4.  A formal risk-benefit framework for genomic tests: facilitating the appropriate translation of genomics into clinical practice.

Authors:  David L Veenstra; Joshua A Roth; Louis P Garrison; Scott D Ramsey; Wylie Burke
Journal:  Genet Med       Date:  2010-11       Impact factor: 8.822
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.